152 related articles for article (PubMed ID: 38557112)
1. Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin B.
Gebremariam T; Alkhazraji S; Gu Y; Najvar LK; Borroto-Esoda K; Patterson TF; Filler SG; Wiederhold NP; Ibrahim AS
Antimicrob Agents Chemother; 2024 May; 68(5):e0154523. PubMed ID: 38557112
[TBL] [Abstract][Full Text] [Related]
2. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis.
Gebremariam T; Gu Y; Singh S; Kitt TM; Ibrahim AS
J Antimicrob Chemother; 2021 Sep; 76(10):2636-2639. PubMed ID: 34263306
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis.
Gu Y; Gebremariam T; Alkhazraji S; Youssef E; El-Gamal S; Matkovits T; Cobb J; Mannino R; Ibrahim AS
Antimicrob Agents Chemother; 2024 Apr; ():e0154023. PubMed ID: 38687015
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
Salas V; Pastor FJ; Calvo E; Alvarez E; Sutton DA; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
Antimicrob Agents Chemother; 2012 May; 56(5):2246-50. PubMed ID: 22290952
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.
Lewis RE; Albert ND; Liao G; Hou J; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2010 Mar; 54(3):1298-304. PubMed ID: 20038620
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.
Lewis RE; Albert ND; Kontoyiannis DP
Antimicrob Agents Chemother; 2014 Nov; 58(11):6767-72. PubMed ID: 25182639
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of an oral lipid nanocrystal (LNC) formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis.
Gu Y; Gebremariam T; Alkhazraji S; Youssef E; El-Gamal S; Matkovits T; Cobb J; Mannino R; Ibrahim AS
bioRxiv; 2023 Nov; ():. PubMed ID: 38045251
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
Gebremariam T; Alkhazraji S; Baldin C; Kovanda L; Wiederhold NP; Ibrahim AS
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264840
[TBL] [Abstract][Full Text] [Related]
10. Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1→3)-β-d-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Naing E; Kavaliauskas P; Barat S; Borroto-Esoda K; Azie N; Angulo D; Walsh TJ
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179521
[TBL] [Abstract][Full Text] [Related]
11. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Rodríguez MM; Pastor FJ; Calvo E; Salas V; Sutton DA; Guarro J
Antimicrob Agents Chemother; 2009 Dec; 53(12):5022-5. PubMed ID: 19786601
[TBL] [Abstract][Full Text] [Related]
12. Posaconazole mono- or combination therapy for treatment of murine zygomycosis.
Ibrahim AS; Gebremariam T; Schwartz JA; Edwards JE; Spellberg B
Antimicrob Agents Chemother; 2009 Feb; 53(2):772-5. PubMed ID: 18936190
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
Luo G; Gebremariam T; Lee H; French SW; Wiederhold NP; Patterson TF; Filler SG; Ibrahim AS
Antimicrob Agents Chemother; 2013 Jul; 57(7):3340-7. PubMed ID: 23650163
[TBL] [Abstract][Full Text] [Related]
14. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F
Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Sex Differences in Murine Diabetic Ketoacidosis and Neutropenic Models of Invasive Mucormycosis.
Gebremariam T; Alkhazraji S; Alqarihi A; Wiederhold NP; Najvar LK; Patterson TF; Filler SG; Ibrahim AS
J Fungi (Basel); 2021 Apr; 7(4):. PubMed ID: 33919611
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis.
Mihara T; Kakeya H; Izumikawa K; Obata Y; Nishino T; Takazono T; Kosai K; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Tsukamoto M; Yamamoto Y; Yanagihara K; Tashiro T; Kohno S
J Infect Chemother; 2014 Feb; 20(2):104-8. PubMed ID: 24462443
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary mucormycosis caused by Rhizopus microsporus].
Lysková P; Žáčková P; Petečuková V; Hubka V; Vašáková M; Matěj R; Čermák J; Kubátová A; Kolařík M; Kozák T; Hricíková I
Klin Mikrobiol Infekc Lek; 2013 Dec; 19(4):132-7. PubMed ID: 24623054
[TBL] [Abstract][Full Text] [Related]
18. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins.
Ibrahim AS; Gebremariam T; Luo G; Fu Y; French SW; Edwards JE; Spellberg B
Antimicrob Agents Chemother; 2011 Apr; 55(4):1768-70. PubMed ID: 21263057
[TBL] [Abstract][Full Text] [Related]
20. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
Salas V; Pastor FJ; Calvo E; Sutton D; García-Hermoso D; Mayayo E; Dromer F; Fothergill A; Alvarez E; Guarro J
Med Mycol; 2012 Oct; 50(7):710-5. PubMed ID: 22458251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]